Longevity.Technology interviews Buck Institute’s President and CEO Eric Verdin
Longevity Technology - 03-Oct-2019Includes updates on NAPA Therapeutics and BHB Therapeutics
Join the club for FREE to access the whole archive and other member benefits.
Focused on a novel target linked to one of the fundamental processes of aging
Formed by the Buck Institute for Research on Aging, Insilico Medicine, and Juvenescence Ltd in 2018.
No company website as of July 2020.
Details last updated 14-Jul-2020
Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
Includes updates on NAPA Therapeutics and BHB Therapeutics
Groundbreaking research biotechs performs aging research together for longevity